- Report
- October 2024
- 199 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Clinical Trials
- April 2025
- 120 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Report
- October 2024
- 189 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 180 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 180 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Report
- December 2024
Japan, United States, ... Japan, United States, Europe, Global
From €16838EUR$18,500USD£14,302GBP
- Report
- February 2025
Japan, United States, ... Japan, United States, Europe, Global
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
United States
From €2275EUR$2,500USD£1,933GBP
- Report
- December 2024
Canada, Mexico, North America Canada, Mexico, North America
From €8647EUR$9,500USD£7,344GBP
- Report
- February 2025
Middle East
From €4096EUR$4,500USD£3,479GBP

Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes.
The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more